The U.S. Drug Enforcement Administration (DEA) is planning to increase the amount of cannabis it authorizes for sole purposes for research use by nearly 30 percent for 2019 while authorizing the production of fewer opioids.
The federal agency published its proposed quotas back in September and after a period of public comment decided to stick with the 3.2 million g of marijuana it initially suggested, Marijuana Moment reported.
Number of recent reports suggest demand for access to high-quality cannabis is on the rise as more states legalize cannabis and look to conduct research into its potential benefits.
Source: Marijuana Moment, DEA
